BioAge Labs (BIOA) Share-based Compensation (2023 - 2026)
BioAge Labs (BIOA) posted Share-based Compensation of $2.7 million for Q4 2025, down 89.88% sequentially from $26.9 million in Q3 2025, and little changed YoY from $2.7 million in Q4 2024.
BioAge Labs (BIOA) Share-based Compensation (2023 - 2026) Analysis & Trends
BioAge Labs has reported Share-based Compensation for 3 years, with the latest figure at $2.7 million in Q4 2025.
- Quarterly Share-based Compensation changed 0.04% year-over-year to $2.7 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $9.1 million (down 1.91% YoY) and the FY2025 annual result came in at $23.8 million, down 9.85% from the prior year.
- Share-based Compensation eased to $2.7 million in Q4 2025 per BIOA's latest filing, from $26.9 million in the prior quarter.
- Over five years, Share-based Compensation peaked at $26.9 million in Q3 2025 and troughed at $282000.0 in Q1 2024.
- A 3-year average of $4.8 million and a median of $2.7 million in 2024 frame the typical range for Share-based Compensation.
- The widest YoY moves for Share-based Compensation: up 1355.63% in 2025, down 0.04% in 2025.
- Over 3 years, Share-based Compensation stood at $757000.0 in 2023, then soared by 259.45% to $2.7 million in 2024, then grew by 0.04% to $2.7 million in 2025.
- According to Business Quant data, Share-based Compensation over the past three periods registered $2.7 million, $26.9 million, and $3.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 40.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 26.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 114.12 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 19.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 30.40 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 65.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 7.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | BioAge Labs | 434.04 Mn | 434.04 Mn | -14.23 Mn | 4.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.27 Mn |
| Jun 30, 2026 | 4.27 Mn |
| Mar 31, 2026 | 4.26 Mn |
| Mar 31, 2026 | 4.26 Mn |
| Dec 31, 2025 | 2.72 Mn |
| Dec 31, 2025 | 2.72 Mn |
| Sep 30, 2025 | 26.90 Mn |
| Sep 30, 2025 | 26.90 Mn |
| Jun 30, 2025 | 3.23 Mn |
| Jun 30, 2025 | 3.23 Mn |
| Mar 31, 2025 | 3.11 Mn |
| Mar 31, 2025 | 3.11 Mn |
| Dec 31, 2024 | 2.72 Mn |
| Dec 31, 2024 | 2.72 Mn |
| Sep 30, 2024 | 1.85 Mn |
| Sep 30, 2024 | 1.85 Mn |
| Jun 30, 2024 | 1.56 Mn |
| Jun 30, 2024 | 1.56 Mn |
| Mar 31, 2024 | 282,000.00 |
| Mar 31, 2024 | 282,000.00 |